OPPORTUNITIES FOR PHARMA INDUSTRY’S RESEARCH COLLABORATIONS WITH CSIR-CDRI

Q4 Pharmacology, Toxicology and Pharmaceutics INDIAN DRUGS Pub Date : 2023-07-03 DOI:10.53879/id.60.06.p0005
{"title":"OPPORTUNITIES FOR PHARMA INDUSTRY’S RESEARCH COLLABORATIONS WITH CSIR-CDRI","authors":"","doi":"10.53879/id.60.06.p0005","DOIUrl":null,"url":null,"abstract":"Dear Reader, Industry can look forward to work with CSIR-CDRI in this new era of dynamic leadership of CSIR, with Dr. (Mrs) N. Kalaiselvi, the new Director General of CSIR and Secretary, DSIR and Dr. (Mrs) Radha Rangarajan, Director, CDRI, Lucknow, who has recently taken charge of this pioneer pharmaceutical research laboratory in India which has a very distinguished track record in drug discovery research from early days, especially from the times of Dr. Nitya Anand, Director of CSIR-CDRI from 1974 to 1984","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"INDIAN DRUGS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53879/id.60.06.p0005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Dear Reader, Industry can look forward to work with CSIR-CDRI in this new era of dynamic leadership of CSIR, with Dr. (Mrs) N. Kalaiselvi, the new Director General of CSIR and Secretary, DSIR and Dr. (Mrs) Radha Rangarajan, Director, CDRI, Lucknow, who has recently taken charge of this pioneer pharmaceutical research laboratory in India which has a very distinguished track record in drug discovery research from early days, especially from the times of Dr. Nitya Anand, Director of CSIR-CDRI from 1974 to 1984
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
制药行业与CSIR-CDRI研究合作的机遇
亲爱的读者,业界期待着在CSIR充满活力的领导新时代与CSIR-CDRI合作,与CSIR新任总干事兼DSIR秘书N.Kalaiselvi博士(夫人)和勒克瑙CDRI董事Radha Rangarajan博士(女士)合作,他最近负责印度这家先驱药物研究实验室,该实验室从早期开始就在药物发现研究方面有着杰出的记录,尤其是从1974年至1984年担任CSIR-CDRI主任的Nitya Anand博士开始
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
INDIAN DRUGS
INDIAN DRUGS Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
0.30
自引率
0.00%
发文量
98
期刊最新文献
COMPUTATIONAL IDENTIFICATION OF SELECTED BIOACTIVE COMPOUNDS FROM CEDRUS DEODARA AS INHIBITORS AGAINST SARS-COV-2 MAIN PROTEASE: A PHARMACOINFORMATICS STUDY PREPARATION AND CHARACTERIZATION OF MICROSPHERES UTILIZING RATE-CONTROLLING MEMBRANES FOR THE MANAGEMENT OF DIABETES MELLITUS PHYSICOCHEMICAL AND PHARMACOKINETIC ANALYSIS AND DOCKING OF DRUG REPOSITIONING AGAINST SARS-COV-2: AN IN SILICO STUDY NEED/ROLE OF GENERATIVE AI IN PHARMACEUTICAL RESEARCH THE GENUS LITSEA: A REVIEW OF ITS CYTOTOXIC POTENTIAL AND PHYTOCHEMISTRY
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1